Humana (NYSE:HUM) Trading 0.5% Higher

Humana Inc. (NYSE:HUM - Get Free Report)'s share price traded up 0.5% during mid-day trading on Tuesday . The company traded as high as $322.71 and last traded at $320.85. 160,952 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 1,964,446 shares. The stock had previously closed at $319.23.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. TheStreet lowered shares of Humana from a "b" rating to a "c+" rating in a report on Monday, January 8th. Truist Financial reiterated a "hold" rating and issued a $550.00 price objective on shares of Humana in a research report on Friday, January 19th. Argus cut Humana from a "buy" rating to a "hold" rating in a research report on Wednesday, March 13th. UBS Group dropped their price target on Humana from $334.00 to $326.00 and set a "neutral" rating for the company in a research report on Thursday, April 25th. Finally, Raymond James assumed coverage on shares of Humana in a research report on Friday, March 22nd. They issued a "market perform" rating on the stock. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $424.50.

Humana Trading Up 1.7 %

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The stock has a market capitalization of $39.12 billion, a P/E ratio of 20.21, a P/E/G ratio of 1.86 and a beta of 0.49. The firm's 50 day moving average price is $323.08 and its 200 day moving average price is $385.94.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to analysts' expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business's revenue was up 10.7% on a year-over-year basis. During the same quarter last year, the business posted $9.38 EPS. As a group, equities research analysts expect that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. The ex-dividend date of this dividend is Friday, June 28th. Humana's dividend payout ratio is presently 22.04%.

Insider Activity at Humana

In other news, Director Jorge S. Mesquita acquired 545 shares of the firm's stock in a transaction that occurred on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the acquisition, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.29% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Cambridge Investment Research Advisors Inc. raised its holdings in Humana by 30.0% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 9,196 shares of the insurance provider's stock worth $4,474,000 after purchasing an additional 2,124 shares during the period. Stratos Wealth Partners LTD. raised its stake in shares of Humana by 4.2% in the third quarter. Stratos Wealth Partners LTD. now owns 1,294 shares of the insurance provider's stock worth $630,000 after buying an additional 52 shares during the period. Brown Advisory Inc. lifted its position in shares of Humana by 17.3% during the 3rd quarter. Brown Advisory Inc. now owns 2,311 shares of the insurance provider's stock valued at $1,124,000 after buying an additional 341 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Humana by 10.2% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 44,643 shares of the insurance provider's stock valued at $21,720,000 after acquiring an additional 4,138 shares during the period. Finally, Mackenzie Financial Corp increased its holdings in Humana by 80.8% in the 3rd quarter. Mackenzie Financial Corp now owns 69,277 shares of the insurance provider's stock worth $33,838,000 after acquiring an additional 30,964 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.